Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2Phase 1/2 1

Status

Recruiting 3Active not recruiting 2

Sponsor Class

INDUSTRY 5

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 72Genitourinary 8Head & Neck 7Thoracic 5Other solid neoplasm 5Gynecologic 4Tumor-Agnostic 2Sarcoma 2Dermatologic 2CNS 2Endocrine 1Breast 1

Conditions

Advanced Solid Tumors 2Solid Tumors 1Malignant Solid Tumor 1Advanced Solid Tumour 1

Interventions

pembrolizumab 15Injections 13Pemetrexed 8Carboplatin 8tislelizumab 6Interviews as Topic 6Standard of Care 5Specimen Handling 5Practice Guidelines as Topic 5Fluorouracil 5Cisplatin 5Bevacizumab 5atezolizumab 4Oxaliplatin 4Docetaxel 4sotorasib 3fludarabine 3Paclitaxel 3Nivolumab 3Methods 3Leucovorin 3Irinotecan 3Educational Status 3Early Intervention, Educational 3Capecitabine 3toripalimab 2Radiotherapy, Intensity-Modulated 2Patient Navigation 2Magnetic Resonance Spectroscopy 2Gemcitabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Fluorouracil × Other solid neoplasm × 30 days × Clear all
NCT05067283 2026-05-26

KANDLELIT-001

Merck Sharp & Dohme LLC

Phase 1 Recruiting
830 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT07331155 2026-05-18

A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)]

Nanjing Leads Biolabs Co.,Ltd

Phase 2 Recruiting
110 enrolled
Other solid neoplasm

Advanced Solid Tumour

NCT07415031 2026-05-15

A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies

Mirati Therapeutics Inc.

Phase 2 Recruiting
170 enrolled
Other solid neoplasm

Solid Tumors

NCT05083481 2026-05-05

A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid Tumors

Astellas Pharma Inc

Phase 1/2 Active not recruiting
226 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT06057038 2026-05-05

A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors

Genmab

Phase 1 Active not recruiting
42 enrolled
Other solid neoplasm

Malignant Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡